GlassScriptPhysician profile
Patrick J Fitzsimmons
NPI 1215982673
$1,921.89
in general payments reported to CMS, 2019-2025
26 companies · $410 in 2025
The $410 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $574 · 2020: $155 · 2021: $38.78 · 2022: $127 · 2023: $376 · 2024: $242 · 2025: $410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,028.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,027.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $336.73 | 2021-2025 | Symplicity G3, Ffrangio, Onyx Frontier |
| Abiomed | $241.66 | 2021-2024 | Impella |
| Novartis Pharmaceuticals Corporation | $168.53 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $160.91 | 2019-2021 | |
| Saluda Medical Americas, INC. | $119.30 | 2023 | Evoke Scs |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $114.49 | 2019-2025 | Lifevest |
| Kiniksa Pharmaceuticals International, Plc | $106.09 | 2024 | Arcalyst |
| Pfizer INC. | $84.39 | 2023 | |
| Amgen INC. | $82.09 | 2019 | |
| Abbott Laboratories | $73.62 | 2019-2020 | |
| Lantheus Medical Imaging, INC. | $44.96 | 2019-2020 | |
| Medtronic Vascular, INC. | $43.52 | 2019-2020 | |
| Stryker Corporation | $42.64 | 2025 | Flowstasis |
| Amarin Pharma, INC. | $41.93 | 2019 | |
| Impulse Dynamics (USA) INC. | $31.44 | 2023 | Optimizer |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $30.83 | 2023 | Flexitouch Plus, Entre Plus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.37 | 2019 | |
| Irhythm Technologies, INC. | $27.30 | 2022 | |
| Sanofi-Aventis U.S. LLC | $24.34 | 2019 | |
| Inspire Medical Systems, INC. | $21.90 | 2023 | Inspire |
| Astrazeneca Pharmaceuticals LP | $19.58 | 2023 | Farxiga |
| Chiesi USA, INC. | $18.25 | 2025 | Kengreal |
| Siemens Medical Solutions USA, INC. | $17.78 | 2023 | Acuson Sc2000 Diagnostic Ultrasound System |
| Boston Scientific Corporation | $14.64 | 2020 | |
| Merck Sharp & Dohme LLC | $13.65 | 2024 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $12.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Fitzsimmons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.